NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Dan88: I am very skewd towards the view you've expressed versus those others (assumingly premised on the use of fast stochastics):

Well, that strategy is no longer useful one, and the pattern of the past, in my opinion has long gone as some institutions have truly shown their interests and increased their positions.

Other institutions will follow just as most retail investors tend to follow the tide up not buy at valley. The recent days of pause of buying may just be faked pause, and we will see it very clearly within short period of time.

This is 2015, not 2014 nor 2013, a year full of catalysts and ever clear picture of high chance of successes of nwbo in both DCVax-L and DCVax-D.

Any traders will tend to trade less and less, and new positions from both institutions and retail will pile on if usual trading pattern for a biotech company also holds true in the case of nwbo.

I see no sign of otherwise, but steady build up in both share counts and share price from institutions and retail investors.

.

Since the start of the year selling by weak or over concentrated retail shareholders were dealt with by the large absorption by institutions due to:
1)late Nov announcement in late Nov funding by Sir Neil Woodford causing other portfolio managers to do their own due diligence during the Holiday periods; and Sir Woodford's 10.9% position just recently confirmed via an SEC 13D for the investment world;
2)CEO LP's last presentation transcript in early Jan '15 ("In the forefront of Immuno-Oncology" etc)
3)the early March Forbes article depicting upcoming portfolio manager 12 yr performance beat over his peers,
4)Just the beginning of change in direction of short interest: beginning of decline (shorts covering)!
4) Same day results of AF's commentary last week: NO EFFECT (A first in NWBO's long ordeal with AF)
5) IF John1045's post today 30713 rings true:WOW!:

:
John - there are no open DcVax trials for recurrent GBM in the USA now and none are planned according to all, including the company that makes it (yes, I called). They do have them in England and Germany with very long waiting periods which as we all know is criminal given the diagnosis.

As previously stated: More risk in being out of NWBO versus holding or buying it.

Therefore the use of fast stochastics by some prominent posters here may be limited IMHO based on all of the above as institutions test out the mettle of sellers.

Key IMHO is doing a supply demand analysis of April Call Option activity which no one has ventured forward:
1)Only parties supplying shares here would be sizable retail owners?
2)Buyers could be institutions or hedged shorts: THAT analysis is critical IMHO to level of share propellant. As I've stated I do NOT deal with options as I feel the common shares offer enough risk for me.

For the reasons above any share decline may be limited (UNLIKE PAST NWBO share declines) in the face of upcoming short term HC trade conferences attended by NWBO.

Note the shares have declined Thurs and Friday.
MONDAY??

In the past the shares would have declined much more and in the past would just be the beginning of the interim correction IMHO....unlike what took place on each day.